BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 36352227)

  • 1. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity.
    Xue R; Zhang Q; Cao Q; Kong R; Xiang X; Liu H; Feng M; Wang F; Cheng J; Li Z; Zhan Q; Deng M; Zhu J; Zhang Z; Zhang N
    Nature; 2022 Dec; 612(7938):141-147. PubMed ID: 36352227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
    Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil.
    Peng H; Wu X; Liu S; He M; Tang C; Wen Y; Xie C; Zhong R; Li C; Xiong S; Liu J; Zheng H; He J; Lu X; Liang W
    Clin Transl Med; 2023 Jul; 13(7):e1340. PubMed ID: 37491740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment.
    Wang L; Liu Y; Dai Y; Tang X; Yin T; Wang C; Wang T; Dong L; Shi M; Qin J; Xue M; Cao Y; Liu J; Liu P; Huang J; Wen C; Zhang J; Xu Z; Bai F; Deng X; Peng C; Chen H; Jiang L; Chen S; Shen B
    Gut; 2023 May; 72(5):958-971. PubMed ID: 35688610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell Profiling of Tumor-Associated Neutrophils in Advanced Non-Small Cell Lung Cancer.
    Shi J; Li J; Wang H; Li X; Wang Q; Zhao C; Cheng L; Han R; Chen P; Guo H; Tang Z; Zhou C; Zhang Z; Wu F
    Lung Cancer (Auckl); 2023; 14():85-99. PubMed ID: 38025400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing neutrophil plasticity for HCC immunotherapy.
    Ramon-Gil E; Geh D; Leslie J
    Essays Biochem; 2023 Sep; 67(6):941-955. PubMed ID: 37534829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer.
    Yang M; Zhang G; Wang Y; He M; Xu Q; Lu J; Liu H; Xu C
    Br J Cancer; 2020 Oct; 123(9):1404-1416. PubMed ID: 32778818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Infiltrating PD-L1+ Neutrophils Induced by GM-CSF Suppress T Cell Function in Laryngeal Squamous Cell Carcinoma and Predict Unfavorable Prognosis.
    Tang D; Zhang D; Heng Y; Zhu XK; Lin HQ; Zhou J; Tao L; Lu LM
    J Inflamm Res; 2022; 15():1079-1097. PubMed ID: 35210813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment.
    Zhang Y; Guoqiang L; Sun M; Lu X
    Cancer Biol Med; 2020 Feb; 17(1):32-43. PubMed ID: 32296575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil diversity and plasticity in tumour progression and therapy.
    Jaillon S; Ponzetta A; Di Mitri D; Santoni A; Bonecchi R; Mantovani A
    Nat Rev Cancer; 2020 Sep; 20(9):485-503. PubMed ID: 32694624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-associated neutrophils secrete AGR2 to promote colorectal cancer metastasis via its receptor CD98hc-xCT.
    Tian S; Chu Y; Hu J; Ding X; Liu Z; Fu D; Yuan Y; Deng Y; Wang G; Wang L; Wang Z
    Gut; 2022 Dec; 71(12):2489-2501. PubMed ID: 35086885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy.
    Wu Q; Mao H; Jiang Z; Tang D
    Immunology; 2024 Jul; 172(3):343-361. PubMed ID: 38402904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil infiltration mediated by CXCL5 accumulation in the laryngeal squamous cell carcinoma microenvironment: A mechanism by which tumour cells escape immune surveillance.
    Zhang D; Zhou J; Tang D; Zhou L; Chou L; Chou KY; Tao L; Lu LM
    Clin Immunol; 2017 Feb; 175():34-40. PubMed ID: 27876461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil Heterogeneity in Cancer: From Biology to Therapies.
    Lecot P; Sarabi M; Pereira Abrantes M; Mussard J; Koenderman L; Caux C; Bendriss-Vermare N; Michallet MC
    Front Immunol; 2019; 10():2155. PubMed ID: 31616408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-associated neutrophils in patients with cancer.
    Shaul ME; Fridlender ZG
    Nat Rev Clin Oncol; 2019 Oct; 16(10):601-620. PubMed ID: 31160735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using macrophage activation to augment immunotherapy of established tumours.
    Fridlender ZG; Jassar A; Mishalian I; Wang LC; Kapoor V; Cheng G; Sun J; Singhal S; Levy L; Albelda SM
    Br J Cancer; 2013 Apr; 108(6):1288-97. PubMed ID: 23481183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated neutrophils activated by tumor-derived CCL20 (C-C motif chemokine ligand 20) promote T cell immunosuppression via programmed death-ligand 1 (PD-L1) in breast cancer.
    Kwantwi LB; Wang S; Zhang W; Peng W; Cai Z; Sheng Y; Xiao H; Wang X; Wu Q
    Bioengineered; 2021 Dec; 12(1):6996-7006. PubMed ID: 34519637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms.
    Kim IS; Gao Y; Welte T; Wang H; Liu J; Janghorban M; Sheng K; Niu Y; Goldstein A; Zhao N; Bado I; Lo HC; Toneff MJ; Nguyen T; Bu W; Jiang W; Arnold J; Gu F; He J; Jebakumar D; Walker K; Li Y; Mo Q; Westbrook TF; Zong C; Rao A; Sreekumar A; Rosen JM; Zhang XH
    Nat Cell Biol; 2019 Sep; 21(9):1113-1126. PubMed ID: 31451770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.